Neuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies. [electronic resource]
- Oncotarget Jul 2016
- 45042-45051 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.8648 doi
Antineoplastic Agents--therapeutic use Biomarkers, Tumor--analysis Disease-Free Survival Female Humans Male Neoplasms--metabolism Neuregulins--biosynthesis Prognosis Receptor, ErbB-3--antagonists & inhibitors Treatment Outcome